Business Description
Lifecore Biomedical Inc
NAICS : 325412
SIC : 2833
ISIN : US5147661046
Total Employee Number:
382Compare
Compare
Traded in other countries / regions
LFCR.USALDE.Germany Index Membership
Russell 2000Russell 3000Russell 3000Russell 2000 IPO Date
1996-02-15Description
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.14 | |||||
Equity-to-Asset | -0.13 | |||||
Debt-to-Equity | -5.23 | |||||
Debt-to-EBITDA | -66.76 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -0.4 | |||||
Beneish M-Score | -3.45 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -0.7 | |||||
3-Year EPS without NRI Growth Rate | -53.9 | |||||
3-Year FCF Growth Rate | 39.7 | |||||
3-Year Book Growth Rate | -77 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.05 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 21.85 | |||||
9-Day RSI | 33.39 | |||||
14-Day RSI | 40.73 | |||||
3-1 Month Momentum % | 37.02 | |||||
6-1 Month Momentum % | -39.21 | |||||
12-1 Month Momentum % | -38.77 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.79 | |||||
Quick Ratio | 2.41 | |||||
Cash Ratio | 1.01 | |||||
Days Inventory | 174.45 | |||||
Days Sales Outstanding | 99.59 | |||||
Days Payable | 44.12 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -7.9 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 28.91 | |||||
Operating Margin % | -5.33 | |||||
Net Margin % | -28.78 | |||||
EBITDA Margin % | -2.46 | |||||
FCF Margin % | 7.56 | |||||
OCF Margin % | 13.01 | |||||
ROA % | -11.21 | |||||
ROIC % | -2.39 | |||||
3-Year ROIIC % | 9.53 | |||||
ROC (Joel Greenblatt) % | -3.81 | |||||
ROCE % | -2.96 | |||||
Years of Profitability over Past 10-Year | 4 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 2.05 | |||||
Price-to-Free-Cash-Flow | 26.81 | |||||
Price-to-Operating-Cash-Flow | 15.69 | |||||
EV-to-EBIT | -51.28 | |||||
EV-to-EBITDA | -140.93 | |||||
EV-to-Forward-EBITDA | 14.96 | |||||
EV-to-Revenue | 3.46 | |||||
EV-to-Forward-Revenue | 2.49 | |||||
EV-to-FCF | 45.79 | |||||
Price-to-GF-Value | 0.76 | |||||
Price-to-Median-PS-Value | 1.41 | |||||
Earnings Yield (Greenblatt) % | -1.95 | |||||
FCF Yield % | 3.69 | |||||
Forward Rate of Return (Yacktman) % | 23.6 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:LFCR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Lifecore Biomedical Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 90.746 | ||
| EPS (TTM) ($) | -0.78 | ||
| Beta | 1.379 | ||
| 3-Year Sharpe Ratio | 0.04 | ||
| 3-Year Sortino Ratio | 0.05 | ||
| Volatility % | 72.19 | ||
| 14-Day RSI | 40.73 | ||
| 14-Day ATR ($) | 0.301152 | ||
| 20-Day SMA ($) | 5.501 | ||
| 12-1 Month Momentum % | -38.77 | ||
| 52-Week Range ($) | 3.625 - 8.9799 | ||
| Shares Outstanding (Mil) | 37.51 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Lifecore Biomedical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Lifecore Biomedical Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-06 16:30 | In 130 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 | In 129 days | ||
| General meeting for 2026 | 2026-10-29 10:30 | In 122 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-31 | In 62 days | ||
| Second quarter earnings results for 2026 | 2026-08-31 | In 62 days | ||
| Annual report for 2026 | 2026-06-02 | 4.85 (-2.41%) | ||
| First quarter earnings conference call for 2026 | 2026-05-06 08:00 | 5.16 (+0.58%) | ||
| First quarter earnings results for 2026 | 2026-05-06 | 5.16 (+0.58%) | ||
| 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum | 2026-03-17 09:00 | 4.37 (-31.26%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-16 08:30 | 6.54 (-1.36%) |
Show
Entries
Lifecore Biomedical Inc Frequently Asked Questions
What is Lifecore Biomedical Inc(LFCR)'s stock price today?
The current price of LFCR is $4.97. The 52 week high of LFCR is $8.98 and 52 week low is $3.63.
When is next earnings date of Lifecore Biomedical Inc(LFCR)?
The next earnings date of Lifecore Biomedical Inc(LFCR) is 2026-08-31 Est..
Does Lifecore Biomedical Inc(LFCR) pay dividends? If so, how much?
Lifecore Biomedical Inc(LFCR) does not pay dividend.
Press Release
Articles on Lifecore Biomedical Inc
No articles.
Headlines
See More- 1
Jun 15, 2026
Lifecore Biomedical Signs New Agreement with Global Pharmaceutical Company
Benzinga • 6:05am
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers